Open Access

Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system

Kamila Bulak

Kamila Bulak

Department of Pathomorphology and Forensic Veterinary Medicine, University of Life Sciences in LublinLublin, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Bulak, Kamila
, 
Anna Kycko

Anna Kycko

Department of Pathology, National Veterinary Research InstitutePuławy, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Kycko, Anna
, 
Anna Śmiech

Anna Śmiech

Department of Pathomorphology and Forensic Veterinary Medicine, University of Life Sciences in LublinLublin, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Śmiech, Anna
 and 
Wojciech Łopuszyński

Wojciech Łopuszyński

Department of Pathomorphology and Forensic Veterinary Medicine, University of Life Sciences in LublinLublin, Poland
Orcid profile
Search for this author on
Sciendo|Google Scholar
Łopuszyński, Wojciech
  
Dec 19, 2023
Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Dec 19, 2023
Page range: 611 - 618
Received: Jul 22, 2023
Accepted: Nov 22, 2023
DOI: https://doi.org/10.2478/jvetres-2023-0066
Keywords
© 2023 Kamila Bulak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Fig. 1.

Staining of mast cell tumours (MCTs). A – Haematoxylin & eosin (H&E) staining visualising a high degree of cell differentiation in a grade 1 MCT; B – H&E staining visualising an intermediate degree of cell differentiation in a grade 2 MCT; C – H&E staining visualising poorly differentiated neoplastic cells in a grade 3 MCT; D – Intense toluidine blue staining visualising intracytoplasmic granules of neoplastic mast cells in a grade 1 MCT; E – Toluidine blue staining visualising individual cells in a grade 2 MCT; F – Weak toluidine blue staining visualising a grade 3 MCT
Staining of mast cell tumours (MCTs). A – Haematoxylin & eosin (H&E) staining visualising a high degree of cell differentiation in a grade 1 MCT; B – H&E staining visualising an intermediate degree of cell differentiation in a grade 2 MCT; C – H&E staining visualising poorly differentiated neoplastic cells in a grade 3 MCT; D – Intense toluidine blue staining visualising intracytoplasmic granules of neoplastic mast cells in a grade 1 MCT; E – Toluidine blue staining visualising individual cells in a grade 2 MCT; F – Weak toluidine blue staining visualising a grade 3 MCT

Fig. 2.

Frequency of immunoreactivity for matrix metalloproteinase 1 (MMP-1) receptor protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **– P-value < 0.01; ***– P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction
Frequency of immunoreactivity for matrix metalloproteinase 1 (MMP-1) receptor protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **– P-value < 0.01; ***– P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction

Fig. 3.

Immunohistochemistry with anti-matrix metalloproteinase 1 (MMP-1) primary antibody with positive reaction visible as brown staining. A – strong cytoplasmic reaction in a grade 1 mast cell tumours (MCTs); B – moderate cytoplasmic reaction in a grade 2 MCT; C – weak cytoplasmic reaction in a grade 3 MCT
Immunohistochemistry with anti-matrix metalloproteinase 1 (MMP-1) primary antibody with positive reaction visible as brown staining. A – strong cytoplasmic reaction in a grade 1 mast cell tumours (MCTs); B – moderate cytoplasmic reaction in a grade 2 MCT; C – weak cytoplasmic reaction in a grade 3 MCT

Fig. 4.

Frequency of immunoreactivity for p21 protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **_ P-value < 0.01; *** P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction
Frequency of immunoreactivity for p21 protein in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; **_ P-value < 0.01; *** P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction

Fig. 5.

Immunohistochemistry with primary anti-p21 antibody with positive reaction visible as brown staining. A – weak nuclear reaction in a grade 1 mast cell tumour (MCT); B – moderate nuclear reaction in a grade 2 MCT; C – strong nuclear reaction in a grade 3 MCT
Immunohistochemistry with primary anti-p21 antibody with positive reaction visible as brown staining. A – weak nuclear reaction in a grade 1 mast cell tumour (MCT); B – moderate nuclear reaction in a grade 2 MCT; C – strong nuclear reaction in a grade 3 MCT

Fig. 6.

Frequency of immunoreactivity for cannabinoid type 2 receptor proteins in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; ** – P-value < 0.01; *** – P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction
Frequency of immunoreactivity for cannabinoid type 2 receptor proteins in grade 1, 2 and 3 mast cell tumours (MCTs). * – P-value < 0.05; ** – P-value < 0.01; *** – P-value < 0.001 compared to grade 1 MCTs; (−) – no reaction; (+) – weak reaction; (++) – moderate reaction; (+++) – strong reaction

Fig. 7.

Immunohistochemistry with primary anti–cannabinoid type2 receptor antibody with positive reaction visible as brown staining. A – moderate to strong cytoplasmic reaction in a grade 1 mast cell tumour (MCT); B – moderate cytoplasmic reaction in a grade 2 MCT; C – weak cytoplasmic reaction in a grade 3 MCT
Immunohistochemistry with primary anti–cannabinoid type2 receptor antibody with positive reaction visible as brown staining. A – moderate to strong cytoplasmic reaction in a grade 1 mast cell tumour (MCT); B – moderate cytoplasmic reaction in a grade 2 MCT; C – weak cytoplasmic reaction in a grade 3 MCT
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Microbiology and Virology, Life Sciences, other, Medicine, Veterinary Medicine
Journal RSS Feed